ALZAMEND NEURO, INC. (ALZN) Operating cash flow 2020–2026
ALZAMEND NEURO, INC. (ALZN) annual operating cash flow history from SEC filings — net cash provided by operating activities each fiscal year.
-$8.1MFY2026 · since FY2020: -$2.3M → -$8.1M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2026 | -$8.1M | -22.8% |
| FY2025 | -$6.6M | +20.6% |
| FY2024 | -$8.3M | +7.3% |
| FY2023 | -$8.9M | -34.9% |
| FY2022 | -$6.6M | -143.9% |
| FY2021 | -$2.7M | -15.6% |
| FY2020 | -$2.3M | — |
Source: SEC XBRL filings · For reference only · Not investment advice
More ALZN financial trends
ALZN RevenueALZN Net incomeALZN Net marginALZN Gross profitALZN Gross marginALZN Operating incomeALZN Operating marginALZN Free cash flowALZN Capital expendituresALZN Return on equityALZN Stock buybacksALZN Dividends paidALZN Total assetsALZN Total liabilitiesALZN Shareholders’ equityALZN overview →